Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology - Quiz - MDSpire

Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology

  • By

  • Xiaoxuan Xing

  • Ke Wang

  • Yingnan Feng

  • Chao Wu

  • Lihua Jia

  • Huiying Li

  • Zhiyong Wen

  • Yinan Tang

  • Zhizhou Wang

  • Xiaotong Zhang

  • Xiaoxi Li

  • Yiming Hua

  • Lan Zhang

  • Xianzhe Dong

  • June 22, 2026

  • 0 min

Share

Original Source(s)

Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology

  • by Xiaoxuan Xing, Ke Wang, Yingnan Feng, Chao Wu, Lihua Jia, Huiying Li, Zhiyong Wen, Yinan Tang, Zhizhou Wang, Xiaotong Zhang, Xiaoxi Li, Yiming Hua, Lan Zhang, Xianzhe Dong

  • June 22, 2026

Related Content

Oculomics: Beyond the Buzzword

Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo

Quitting Smoking Linked to Lower Risk for Dementia